Ovoca Bio plc (AIM:OVB)
London · Delayed Price · Currency is GBP · Price in GBX 1.150
-0.125 (-9.80%)
May 6, 2025, 11:10 AM GMT+1
Ovoca Bio Market Cap
Ovoca Bio has a market cap or net worth of 937.98 thousand as of September 8, 2025. Its market cap has increased by 72.93% in one year.
Market Cap
937.98K
Enterprise Value
-1.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.15
Market Cap Chart
Since July 4, 2005, Ovoca Bio's market cap has decreased from 4.53M to 937.98K, a decrease of -79.28%. That is a compound annual growth rate of -7.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2025 | 937.98K | -28.12% |
| Dec 31, 2024 | 1.31M | 77.78% |
| Dec 29, 2023 | 734.07K | -81.54% |
| Dec 30, 2022 | 3.98M | -66.38% |
| Dec 31, 2021 | 11.83M | 61.11% |
| Dec 31, 2020 | 7.34M | -23.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |